Trial Profile

Immunogenicity and Safety of PEDIACEL, a Combined Diphtheria, Tetanus, Five Component Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus Influenzae Type b Conjugate Vaccine (Adsorbed), Compared to Infanrix-IPV+Hib When Both Vaccines Are Co-Administered With Prevenar to Infants and Toddlers at 2, 3, 4 and 12-18 Months of Age.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 21 Apr 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hib-DTaP-poliovirus vaccine (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate
Indications Diphtheria; Haemophilus infections; Pertussis; Pneumococcal infections; Poliomyelitis; Tetanus
Focus Pharmacodynamics
Sponsors Sanofi

26 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
07 Apr 2008 The expected completion date for this trial is now 1 Jul 2009, as reported by clinicaltrials.gov.
22 Sep 2006 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com